2011China Medical HeraldRequires access

Clinical observation of post-stroke depression by Buspirone combined with Escitalopram

Hongyan Yu

Open publisher page 0 citations

Abstract

Objective:To compare the effect and safety of Buspirone combined with Escitalopram and Escitalopram used singly in the treatment of post-stroke depression.Methods:Totally the 60 post-stroke depression patients were randomized into control group(n=30),treated with Escitalopram,and study group(n=30),treated by Buspirone combined with Escitalopram.The observation lasted 8 weeks.The therapeutic effect and safety were evaluated by the positive and negative syndrome scale of HAMD(24 items),and treatment emergent symptom scale of TESS.Results:Total effective rate of the study group was 93.3%(28/30) and with the control group 63.3%(23/30),there was a significant difference(χ2=8.91,P=0.031,P0.05),and according to HAMD total scores assessment,there was a significant difference between two groups(P0.05) after the treatment in different weekend.The difference of TESS scores between two groups was not significant.Conclusion:Buspirone combined with Escitalopram is effective and safe in the treatment of post-stroke depression.

About this research paper

What this paper is about

Objective:To compare the effect and safety of Buspirone combined with Escitalopram and Escitalopram used singly in the treatment of post-stroke depression.Methods:Totally the 60 post-stroke depression patients were randomized into control group(n=30),treated with Escitalopram,and study group(n=30),treated by Buspirone combined with Escitalopram.The observation lasted 8 weeks.The therapeutic effect and safety were evaluated by the positive and negative syndrome scale of HAMD(24 items),and treatment emergent symptom scale of TESS.Results:Total effective rate of the study group was 93.3%(28/30) and with the control group 63.3%(23/30),there was a significant difference(χ2=8.91,P=0.031,P0.05),and according to HAMD total scores assessment,there was a significant difference between two groups(P0.05) after the treatment in different weekend.The difference of TESS scores between two groups was not significant.Conclusion:Buspirone combined with Escitalopram is effective and safe in the treatment of post-stroke depression.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To compare the effect and safety of Buspirone combined with Escitalopram and Escitalopram used singly in the treatment of post-stroke depression.Methods:Totally the 60 post-stroke depression patients were randomized into control group(n=30),treated with Escitalopram,and study group(n=30),treated by Buspirone combined with Escitalopram.The observation lasted 8 weeks.The therapeutic effect and safety were evaluated by the positive and negative syndrome scale of HAMD(24 items),and treatment emergent symptom scale of TESS.Results:Total effective rate of the study group was 93.3%(28/30) and with the control group 63.3%(23/30),there was a significant difference(χ2=8.91,P=0.031,P0.05),and according to HAMD total scores assessment,there was a significant difference between two groups(P0.05) after the treatment in different weekend.The difference of TESS scores between two groups was not significant.Conclusion:Buspirone combined with Escitalopram is effective and safe in the treatment of post-stroke depression.

Key concepts: Escitalopram, Buspirone, Hamd, Medicine, Post-stroke depression, Depression (economics), Significant difference, Citalopram

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical observation of post-stroke depression by Buspirone combined with Escitalopram — Research Paper | ScholarLens